Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
104.96 USD | +3.82% | -2.80% | -27.35% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 3.59B | 3.13B | 3.33B | 7.32B | 9.62B | |||||
Total Revenues | 3.59B | 3.13B | 3.33B | 7.32B | 9.62B | |||||
Cost of Goods Sold, Total | 2.33B | 2.13B | 2.32B | 4.24B | 8.42B | |||||
Gross Profit | 1.26B | 997M | 1.01B | 3.08B | 1.2B | |||||
Selling General & Admin Expenses, Total | 439M | 427M | 347M | 439M | 644M | |||||
R&D Expenses | 58.29M | 59.21M | 54.03M | 71.98M | 85.72M | |||||
Other Operating Expenses | - | - | - | - | - | |||||
Other Operating Expenses, Total | 497M | 486M | 401M | 511M | 730M | |||||
Operating Income | 763M | 510M | 607M | 2.57B | 467M | |||||
Interest Expense, Total | -52.87M | -73.12M | -32.52M | -104M | -116M | |||||
Interest And Investment Income | - | - | - | - | 19.3M | |||||
Net Interest Expenses | -52.87M | -73.12M | -32.52M | -104M | -96.77M | |||||
Income (Loss) On Equity Invest. | 130M | 128M | 95.77M | 772M | 1.85B | |||||
Currency Exchange Gains (Loss) | -27.4M | -28.8M | 100K | -21.8M | 39.9M | |||||
Other Non Operating Income (Expenses) | 15.53M | 6.63M | -24.74M | 44.51M | 80.27M | |||||
EBT, Excl. Unusual Items | 827M | 543M | 646M | 3.26B | 2.34B | |||||
Restructuring Charges | -5.88M | -19.9M | -3.03M | -4.3M | -11.8M | |||||
Merger & Related Restructuring Charges | -20.7M | -17.26M | -12.67M | -16.26M | -26.77M | |||||
Impairment of Goodwill | - | - | - | - | -6.76M | |||||
Gain (Loss) On Sale Of Investments | - | 7.2M | - | 4.3M | -39.23M | |||||
Gain (Loss) On Sale Of Assets | 11.1M | 3.6M | 296M | -8.4M | 71.19M | |||||
Asset Writedown | - | - | - | - | - | |||||
Insurance Settlements | - | - | - | - | 7.3M | |||||
Legal Settlements | - | 1.2M | -668M | 100K | -234M | |||||
Other Unusual Items | -119M | -16.5M | -28.96M | -27.62M | -4.1M | |||||
EBT, Incl. Unusual Items | 693M | 501M | 229M | 3.21B | 2.1B | |||||
Income Tax Expense | 88.16M | 54.42M | 29.45M | 391M | 430M | |||||
Earnings From Continuing Operations | 604M | 447M | 200M | 2.82B | 1.67B | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 604M | 447M | 200M | 2.82B | 1.67B | |||||
Minority Interest | -71.13M | -70.85M | -76.27M | -125M | -97.07M | |||||
Net Income - (IS) | 533M | 376M | 124M | 2.69B | 1.57B | |||||
Net Income to Common Incl Extra Items | 533M | 376M | 124M | 2.69B | 1.57B | |||||
Net Income to Common Excl. Extra Items | 533M | 376M | 124M | 2.69B | 1.57B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 5.03 | 3.53 | 1.07 | 22.97 | 13.41 | |||||
Basic EPS - Continuing Operations | 5.03 | 3.53 | 1.07 | 22.97 | 13.41 | |||||
Basic Weighted Average Shares Outstanding | 106M | 106M | 116M | 117M | 117M | |||||
Net EPS - Diluted | 5.02 | 3.52 | 1.06 | 22.84 | 13.36 | |||||
Diluted EPS - Continuing Operations | 5.02 | 3.52 | 1.06 | 22.84 | 13.36 | |||||
Diluted Weighted Average Shares Outstanding | 106M | 107M | 117M | 118M | 118M | |||||
Normalized Basic EPS | 4.21 | 2.52 | 2.83 | 16.32 | 11.66 | |||||
Normalized Diluted EPS | 4.2 | 2.51 | 2.81 | 16.22 | 11.62 | |||||
Dividend Per Share | 1.47 | 1.54 | 1.56 | 1.58 | 1.6 | |||||
Payout Ratio | 28.54 | 43.06 | 143.81 | 6.86 | 11.9 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 976M | 742M | 861M | 2.87B | 897M | |||||
EBITA | 790M | 535M | 633M | 2.59B | 495M | |||||
EBIT | 763M | 510M | 607M | 2.57B | 467M | |||||
EBITDAR | 1.02B | 797M | 923M | 2.93B | 991M | |||||
Effective Tax Rate - (Ratio) | 12.73 | 10.86 | 12.84 | 12.18 | 20.48 | |||||
Current Domestic Taxes | 26.71M | -333K | 12.42M | 38.2M | -57.64M | |||||
Current Foreign Taxes | 47.06M | 56.73M | 55.53M | 259M | 387M | |||||
Total Current Taxes | 73.77M | 56.4M | 67.95M | 297M | 329M | |||||
Deferred Domestic Taxes | 5.89M | 1.67M | -43.96M | 80.54M | -12.7M | |||||
Deferred Foreign Taxes | 8.51M | -3.65M | 5.46M | 12.8M | 114M | |||||
Total Deferred Taxes | 14.39M | -1.98M | -38.5M | 93.34M | 101M | |||||
Normalized Net Income | 446M | 268M | 327M | 1.91B | 1.37B | |||||
Interest Capitalized | 30.2M | 30.4M | 50M | 31.1M | 72.7M | |||||
Interest on Long-Term Debt | 83.1M | 104M | 82.48M | 135M | 189M | |||||
Non-Cash Pension Expense | 19.36M | 41.41M | -77.37M | -48.09M | -2.95M | |||||
Supplemental Operating Expense Items | ||||||||||
Research And Development Expense From Footnotes | 58.29M | 59.21M | 54.03M | 71.98M | 85.72M | |||||
Net Rental Expense, Total | 48.19M | 54.26M | 61.42M | 65.86M | 93.62M | |||||
Imputed Operating Lease Interest Expense | 13.09M | 13.03M | 12.95M | 24.07M | 36.9M | |||||
Imputed Operating Lease Depreciation | 35.1M | 41.23M | 48.48M | 41.79M | 56.72M | |||||
Stock-Based Comp., Other (Total) | 21.3M | 19.3M | 18.8M | 31.4M | 39M | |||||
Total Stock-Based Compensation | 21.3M | 19.3M | 18.8M | 31.4M | 39M |